Looking for “exciting biotech plays that won’t break the bank”? Today’s article highlights three such plays, all of which are trading under $3 per share, are Buy-rated, and “boast colossal long-term growth prospects, with upside potential of at least 200%.” For the names and details of these three biotech stocks, CLICK HERE.